{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:46:08Z","timestamp":1794210368850,"version":"4.8.0"},"reference-count":56,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL072166"],"award-info":[{"award-number":["HL072166"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL153614"],"award-info":[{"award-number":["HL153614"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS124846"],"award-info":[{"award-number":["NS124846"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32GM-136503"],"award-info":[{"award-number":["T32GM-136503"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Foundation","award":["DGE-1633213"],"award-info":[{"award-number":["DGE-1633213"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Stroke induces complex pathological cascades in the affected brain area, leading to brain injury and functional disability. To fight against cerebral ischemia\/reperfusion-induced neuronal death, numerous neuroprotective strategies and reagents have been studied. However, translation of these neuroprotective drugs to clinical trials has been unsuccessful. To date, the tissue plasminogen activator is still the only FDA-approved drug for treating ischemic stroke. Thus, it is obligatory to identify and validate additional therapeutic strategies for stroke. A stroke rarely occurs without any other pathophysiological condition; but instead, it often has multi-morbidity conditions, one of which is cardiac disease. Indeed, up to half of the stroke cases are associated with cardiac and large artery diseases. As an adequate blood supply is essential for the brain to maintain its normal function, any pathophysiological alterations in the heart are frequently implicated in stroke outcomes. In this review, we summarize some of the cardiovascular factors that influence stroke outcomes and propose that considering these factors in designing stroke therapies should enhance success in clinical trials. We also highlight the recent advances regarding the potential effect of protein aggregates in a peripheral organ, such as in the heart, on ischemic stroke-caused brain injury and functional recovery. Including these and other comorbidity factors in the future therapeutic strategy designs should facilitate translational success toward developing effective combinational therapies for the disorder.<\/jats:p>","DOI":"10.31083\/j.jin2105138","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:45:15Z","timestamp":1659159915000},"source":"Crossref","is-referenced-by-count":13,"title":["Impact of Cardiovascular Diseases on Ischemic Stroke Outcomes"],"prefix":"10.31083","volume":"21","author":[{"given":"Christa C.","family":"Huber","sequence":"first","affiliation":[{"name":"Division of Basic Biomedical Sciences and Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Basic Biomedical Sciences and Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Basic Biomedical Sciences and Center for Brain and Behavior Research, Sanford School of Medicine, University of South Dakota, Vermillion, SD 57069, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Ahmad FB, Anderson RN. The Leading Causes of Death in the us for 2020. The Journal of the American Medical Association. 2021; 325: 1829.","DOI":"10.1001\/jama.2021.5469"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Katan M, Luft A. Global Burden of Stroke. Seminars in Neurology. 2018; 38: 208\u2013211.","DOI":"10.1055\/s-0038-1649503"},{"key":"ref3","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics\u20132022 Update: A Report From the American Heart Association. Circulation. 2022; 145: e153\u2013e639."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, et al. Forecasting the Future of Stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013; 44: 2361\u20132375.","DOI":"10.1161\/STR.0b013e31829734f2"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lattanzi S, Rinaldi C, Cagnetti C, Foschi N, Norata D, Broggi S, et al. Predictors of Pharmaco\u2013Resistance in Patients with Post\u2013Stroke Epilepsy. Brain Sciences. 2021; 11: 418.","DOI":"10.3390\/brainsci11040418"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. International Journal of Molecular Sciences. 2020; 21: 7609.","DOI":"10.3390\/ijms21207609"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Liu S, Levine SR, Winn HR. Targeting ischemic penumbra: part I \u2013 from pathophysiology to therapeutic strategy. Journal of Experimental Stroke & Translational Medicine. 2010; 3: 47\u201355.","DOI":"10.6030\/1939-067X-3.1.47"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Nelson MLA, Hanna E, Hall S, Calvert M. What Makes Stroke Rehabilitation Patients Complex? Clinician Perspectives and the Role of Discharge Pressure. Journal of Comorbidity. 2016; 6: 35\u201341.","DOI":"10.15256\/joc.2016.6.63"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Doehner W, Leistner DM, Audebert HJ, Scheitz JF. The role of cardiologists on the stroke unit. European Heart Journal Supplements. 2020; 22: M3\u2013M12.","DOI":"10.1093\/eurheartj\/suaa160"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gallacher KI, Jani BD, Hanlon P, Nicholl BI, Mair FS. Multimorbidity in Stroke. Stroke. 2019; 50: 1919\u20131926.","DOI":"10.1161\/STROKEAHA.118.020376"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Horn JW, Feng T, M\u00f8rkedal B, Strand LB, Horn J, Mukamal K, et al. Obesity and Risk for first Ischemic Stroke Depends on Metabolic Syndrome: the HUNT Study. Stroke. 2021; 52: 3555\u20133561.","DOI":"10.1161\/STROKEAHA.120.033016"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bailey RR, Phad A, McGrath R, Haire\u2013Joshu D. Prevalence of five lifestyle risk factors among U.S. adults with and without stroke. Disability and Health Journal. 2019; 12: 323\u2013327.","DOI":"10.1016\/j.dhjo.2018.11.003"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case\u2013control study. The Lancet. 2016; 388: 761\u2013775.","DOI":"10.1016\/S0140-6736(16)30506-2"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22: 983\u2013988.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta\u2013analysis. Journal of Clinical Neuroscience. 2019; 60: 24\u201330.","DOI":"10.1016\/j.jocn.2018.10.026"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Sposato LA, Lam M, Allen B, Richard L, Shariff SZ, Saposnik G. First\u2013ever ischemic stroke and increased risk of incident heart disease in older adults. Neurology. 2020; 94: e1559\u2013e1570.","DOI":"10.1212\/WNL.0000000000009234"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Joundi RA, Rabinstein AA, Nikneshan D, Tu JV, Fang J, Holloway R, et al. Cardiac Arrest in Acute Ischemic Stroke: Incidence, Predisposing Factors, and Clinical Outcomes. Journal of Stroke and Cerebrovascular Diseases. 2016; 25: 1644\u20131652.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.010"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Prosser J, MacGregor L, Lees KR, Diener H, Hacke W, Davis S. Predictors of Early Cardiac Morbidity and Mortality after Ischemic Stroke. Stroke. 2007; 38: 2295\u20132302.","DOI":"10.1161\/STROKEAHA.106.471813"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lin X, Wang H, Rong X, Huang R, Peng Y. Exploring stroke risk and prevention in China: insights from an outlier. Aging. 2021; 13: 15659\u201315673.","DOI":"10.18632\/aging.203096"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wajngarten M, Silva GS. Hypertension and Stroke: Update on Treatment. European Cardiology. 2019; 14: 111\u2013115.","DOI":"10.15420\/ecr.2019.11.1"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World Journal of Clinical Cases. 2015; 3: 418.","DOI":"10.12998\/wjcc.v3.i5.418"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Li J. Traditional Chinese Medicine in Treating Hypertension. Circulation: Cardiovascular Quality and Outcomes. 2022. 15: e008723.","DOI":"10.1161\/CIRCOUTCOMES.121.008723"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bulwa Z, Gomez CR, Morales\u2013Vidal S, Biller J. Management of Blood Pressure after Acute Ischemic Stroke. Current Neurology and Neuroscience Reports. 2019; 19: 29.","DOI":"10.1007\/s11910-019-0941-z"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Pistoia F, Sacco S, Degan D, Tiseo C, Ornello R, Carolei A. Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation. High Blood Pressure & Cardiovascular Prevention. 2016; 23: 9\u201318.","DOI":"10.1007\/s40292-015-0115-2"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"G\u0105secki D, Kwarciany M, Kowalczyk K, Narkiewicz K, Karaszewski B. Blood Pressure Management in Acute Ischemic Stroke. Current Hypertension Reports. 2020; 23: 3.","DOI":"10.1007\/s11906-020-01120-7"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hong L, Cheng X, Lin L, Bivard A, Ling Y, Butcher K, et al. The blood pressure paradox in acute ischemic stroke. Annals of Neurology. 2019; 85: 331\u2013339.","DOI":"10.1002\/ana.25428"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Dawes M. Why is controlling blood pressure after stroke so difficult? Canadian Medical Association Journal. 2013; 185: 11\u201312.","DOI":"10.1503\/cmaj.121819"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Lip GYH, Gue Y, Zhang J, Chao TF, Calkins H, Potpara T. Stroke Prevention in Atrial Fibrillation. Trends in cardiovascular medicine. 2021. (in press)","DOI":"10.1016\/j.tcm.2021.10.001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Edwards JD, Healey JS, Fang J, Yip K, Gladstone DJ. Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction. Journal of the American Heart Association. 2020; 9: e013227.","DOI":"10.1161\/JAHA.119.013227"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Perera KS, Vanassche T, Bosch J, Swaminathan B, Mundl H, Giruparajah M, et al. Global Survey of the Frequency of Atrial Fibrillation\u2013Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. Stroke. 2016; 47: 2197\u20132202.","DOI":"10.1161\/STROKEAHA.116.013378"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"McIntyre WF, Healey J. Stroke Prevention for Patients with Atrial Fibrillation: beyond the Guidelines. Journal of Atrial Fibrillation. 2017; 9: 1475.","DOI":"10.4022\/jafib.1475"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020; 106: 10\u201317.","DOI":"10.1136\/heartjnl-2019-314898"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Kahwati LC, Asher GN, Kadro ZO, Keen S, Ali R, Coker\u2013Schwimmer E, et al. Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. The Journal of the American Medical Association. 2022; 327: 368.","DOI":"10.1001\/jama.2021.21811"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Wang Y, Qian Y, Smerin D, Zhang S, Zhao Q, Xiong X. Newly Detected Atrial Fibrillation after Acute Stroke: a Narrative Review of Causes and Implications. Cardiology. 2019; 144: 112\u2013121.","DOI":"10.1159\/000502971"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Adelborg K, Sz\u00e9pligeti S, Sundb\u00f8ll J, Horv\u00e1th\u2013Puh\u00f3 E, Henderson VW, Ording A, et al. Risk of Stroke in Patients With Heart Failure: A Population\u2013Based 30\u2013Year Cohort Study. Stroke. 2017; 48: 1161\u20131168.","DOI":"10.1161\/STROKEAHA.116.016022"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Chou Y, Liou J, Cheng C, Tsai M, Lin W, Cheng S, et al. The association of ischaemic stroke in patients with heart failure without atrial flutter\/fibrillation. Heart. 2020; 106: 616\u2013623.","DOI":"10.1136\/heartjnl-2019-315646"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Siedler G, Sommer K, Macha K, Marsch A, Breuer L, Stoll S, et al. Heart Failure in Ischemic Stroke: Relevance for Acute Care and Outcome. Stroke. 2019; 50: 3051\u20133056.","DOI":"10.1161\/STROKEAHA.119.026139"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Kim M, Kim J. Heart and Brain Interconnection \u2013 Clinical Implications of Changes in Brain Function during Heart Failure. Circulation Journal. 2015; 79: 942\u2013947.","DOI":"10.1253\/circj.CJ-15-0360"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Kasner SE, Lattanzi S, Fonseca AC, Elgendy AY. Uncertainties and Controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients with Patent Foramen Ovale. Stroke. 2021; 52: e806\u2013e819.","DOI":"10.1161\/STROKEAHA.121.034778"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Cheng T, Gonzalez JB, Testai FD. Advances and ongoing controversies in PFO closure and cryptogenic stroke. Handbook of Clinical Neurology. 2021; 24: 43\u201356.","DOI":"10.1016\/B978-0-12-819814-8.00009-3"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Hu BR, Martone ME, Jones YZ, Liu CL. Protein Aggregation after Transient Cerebral Ischemia. The Journal of Neuroscience. 2000; 20: 3191\u20133199.","DOI":"10.1523\/JNEUROSCI.20-09-03191.2000"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Ge P, Luo Y, Liu CL, Hu B. Protein Aggregation and Proteasome Dysfunction after Brain Ischemia. Stroke. 2007; 38: 3230\u20133236.","DOI":"10.1161\/STROKEAHA.107.487108"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Hochrainer K, Jackman K, Anrather J, Iadecola C. Reperfusion rather than Ischemia Drives the Formation of Ubiquitin Aggregates after Middle Cerebral Artery Occlusion. Stroke. 2012; 43: 2229\u20132235.","DOI":"10.1161\/STROKEAHA.112.650416"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Kahl A, Blanco I, Jackman K, Baskar J, Milaganur Mohan H, Rodney\u2013Sandy R, et al. Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Scientific Reports. 2018; 8: 2701.","DOI":"10.1038\/s41598-018-21063-z"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Liu Y, Qiao F, Wang H. Enhanced Proteostasis in Post\u2013ischemic Stroke Mouse Brains by Ubiquilin\u20131 Promotes Functional Recovery. Cellular and Molecular Neurobiology. 2017; 37: 1325\u20131329.","DOI":"10.1007\/s10571-016-0451-3"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Liu Y, Lu L, Hettinger CL, Dong G, Zhang D, Rezvani K, et al. Ubiquilin\u20131 Protects Cells from Oxidative Stress and Ischemic Stroke Caused Tissue Injury in Mice. Journal of Neuroscience. 2014; 34: 2813\u20132821.","DOI":"10.1523\/JNEUROSCI.3541-13.2014"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Liu Y, Subedi K, Baride A, Romanova S, Callegari E, Huber CC, et al. Peripherally misfolded proteins exacerbate ischemic stroke\u2013induced neuroinflammation and brain injury. Journal of Neuroinflammation. 2021; 18: 29.","DOI":"10.1186\/s12974-021-02081-7"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Teichberg VI. From the liver to the brain across the blood\u2013brain barrier. Proceedings of the National Academy of Sciences. 2007; 104: 7315\u20137316.","DOI":"10.1073\/pnas.0702450104"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Wang J, Guo X, Kang Z, Qi L, Yang Y, Wang J, et al. Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis. Cellular Reprogramming. 2020; 22: 107\u2013117.","DOI":"10.1089\/cell.2019.0098"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Min J, L\u00fc L, Freeling JL, Martin DS, Wang H. USP14 inhibitor attenuates cerebral ischemia\/reperfusion\u2013induced neuronal injury in mice. Journal of Neurochemistry. 2017; 140: 826\u2013833.","DOI":"10.1111\/jnc.13941"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Hu C, Tian Y, Xu H, Pan B, Terpstra EM, Wu P, et al. Inadequate ubiquitination\u2013proteasome coupling contributes to myocardial ischemia\u2013reperfusion injury. Journal of Clinical Investigation. 2018; 128: 5294\u20135306.","DOI":"10.1172\/JCI98287"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Wu P, Li Y, Cai M, Ye B, Geng B, Li F, et al. Ubiquitin Carboxyl\u2013Terminal Hydrolase L1 of Cardiomyocytes Promotes Macroautophagy and Proteostasis and Protects Against Post\u2013myocardial Infarction Cardiac Remodeling and Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9: 866901.","DOI":"10.3389\/fcvm.2022.866901"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Min JW, Liu Y, Wang D, Qiao F, Wang H. The non\u2013peptidic \u03b4\u2013opioid receptor agonist Tan\u201367 mediates neuroprotection post\u2013ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice. Journal of Neurochemistry. 2018; 144: 336\u2013347.","DOI":"10.1111\/jnc.14265"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Liu Y, Feng S, Subedi K, Wang H. Attenuation of Ischemic Stroke\u2013Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation. Molecular Neurobiology. 2020; 57: 937\u2013948.","DOI":"10.1007\/s12035-019-01788-2"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Liu Y, Min JW, Feng S, Subedi K, Qiao F, Mammenga E, et al. Therapeutic Role of a Cysteine Precursor, OTC, in Ischemic Stroke Is Mediated by Improved Proteostasis in Mice. Translational Stroke Research. 2020; 11: 147\u2013160.","DOI":"10.1007\/s12975-019-00707-w"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Wu S, Du L. Protein Aggregation in the Pathogenesis of Ischemic Stroke. Cellular and Molecular Neurobiology. 2021; 41: 1183\u20131194.","DOI":"10.1007\/s10571-020-00899-y"}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/5\/10.31083\/j.jin2105138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T15:44:30Z","timestamp":1732722270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/5\/10.31083\/j.jin2105138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"alternative-id":["S0219-6352(22)00375-8"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2105138","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"article-number":"138"}}